companydata.dkcompanydata.dk

NORDICCELL ApS: Financial statements 2015

CVR: 27293972

Source: annual report 2015, Danish Business Authority

01/07/2014 – 30/06/2015

NORDICCELL ApS (CVR 27293972) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 4,794,050 and a net result of DKK 1,543,334 compared with DKK 1,214,432 the year before. That is an increase of 25.1% compared with the year before. Equity in the 2015 report amounted to DKK 1,324,775. The solvency ratio was 25.7%. The company had 7 employees in the financial year.

Gross Profit
DKK 4,794,050
Profit/Loss
DKK 1,543,334
Equity
DKK 1,324,775
Total Assets
DKK 5,145,138
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-4.8 mio.1.5 mio.1.3 mio.7
2014-3.8 mio.1.2 mio.1.3 mio.6
2013-2.7 mio.546 t.1.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is NORDICCELL ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About NORDICCELL ApS

NORDICCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Bek-Pedersen. The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 8,909,296 and a net result of DKK 1,701,475 compared with DKK 1,272,903 the year before. Equity in the 2025 report amounted to DKK 4,976,358.

Source: annual report 2025, Danish Business Authority